Finally, the tumor growth suppressive effects of DHE also extended to a MOLM-14 cell xenograft model of MLL-rearranged AML and were DHE dose-responsive at clinically-relevant doses of DHE (Supplemental Fig. 12). The gene discussed is KMT2A; the disease is neoplasm.